Holen Sie sich die Stockscreener-App
83.45
0.82%
-0.69
Finanzdaten der Intra Cellular Therapies Inc-Aktie (ITCI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
9.66%
144.87
|
132.10 | 126.17 | 110.79 | 95.31 |
Operating Expenses
|
0.23%
165.82
|
166.20 | 155.89 | 157.97 | 143.70 |
| Benefits Costs and Expenses |
159.75
|
- | - | - | - |
| Costs And Expenses |
3.88%
159.75
|
166.20 | 155.89 | 157.97 | 143.70 |
| Operating Income/Loss |
38.55%
-20.95
|
-34.10 | -29.71 | -47.18 | -48.39 |
| Income/Loss From Continuing Operations Before Tax |
111.27%
-14.89
|
132.10 | -24.21 | -42.65 | -44.04 |
| Income Tax Expense/Benefit |
19.87%
0.359
|
0.448 | 0.043 | 0.135 | 0.01 |
| Income/Loss From Continuing Operations After Tax |
46.65%
-15.25
|
-28.58 | -24.26 | -42.78 | -44.05 |
|
Net Income/Loss
|
46.65%
-15.25
|
-28.58 | -24.26 | -42.78 | -44.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
71,086%
96.88
|
0.1361 | 96.14 | 95.95 | 95.13 |
| Diluted Average Shares |
71,086%
96.88
|
0.1361 | 96.14 | 95.95 | 95.13 |
| Basic Earnings Per Share |
46.67%
-0.16
|
-0.30 | -0.25 | -0.45 | -0.46 |
| Diluted Earnings Per Share |
46.67%
-0.16
|
-0.30 | -0.25 | -0.45 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.89%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):